1型糖尿病一级亲属相对胰腺体积减小
横截面研究纳入AAB-对照、AAB-一级亲属、AAB+一级亲属(单阳性或多阳性)及新发1型糖尿病患者,用1.5T胰腺MRI测胰腺体积。所有一级亲属组RPVBMI均低于对照,新发患者低于AAB-一级亲属和多阳性AAB+组;胰蛋白酶原在患者中最低。
要点
- 所有一级亲属组RPVBMI均显著低于无糖尿病家族史对照。
- 新发1型糖尿病RPVBMI低于AAB-一级亲属和多阳性AAB+组。
- RPVBMI或可作预测1型糖尿病进展的无创生物标志物。
核心结论
- 所有一级亲属相对胰腺体积(RPVBMI)均显著小于AAB-对照。
- 新发1型糖尿病RPVBMI显著低于AAB-一级亲属和多阳性AAB+组。
- RPVBMI可能作为预测1型糖尿病风险分期的无创新生物标志物。
研究设计与样本
- 横截面研究,五组:AAB-对照49例、AAB-一级亲属61例、AAB+一级亲属67例(单阳性31例、多阳性36例)、新发1型糖尿病52例。
- 空腹行1.5T胰腺MRI,分析胰腺体积及相对胰腺体积(PV/BMI)。
主要发现
- 所有一级亲属组RPVBMI均显著低于对照(均P<0.05)。
- 1型糖尿病患者RPVBMI低于AAB-一级亲属(P<0.0001)和多阳性AAB+组(P≤0.013)。
- 转换数据提示胰蛋白酶原水平在1型糖尿病患者中最低。
临床怎么用
- 可考虑将RPVBMI作为1型糖尿病一级亲属风险分层与进展监测的无创影像指标。
- 关注外分泌胰腺(胰蛋白酶原)与内分泌功能间的旁分泌关系在疾病进展中的潜在作用。
局限性
- 横截面设计无法确定RPVBMI变化与1型糖尿病进展的因果时序。
- 原文未报告随访数据、预测阈值或干预效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Pancreas size is reduced in patients at type 1 diabetes onset and in autoantibody (AAB)-positive donors without diabetes. We sought to determine whether pancreas volume (PV) imaging could improve understanding of the loss of pancreas size in first-degree relatives (FDRs) of patients with type 1 diabetes. We also examined relationships among PV, AAB status, and endocrine and exocrine functions. RESEARCH DESIGN AND METHODS: We conducted a cross-sectional study that included five groups: AAB- control subjects (no diabetes and no first- or second-degree relatives with type 1 diabetes) (N = 49), AAB- FDRs (N = 61), AAB+ FDRs (N = 67 total: n = 31 with a single positive AAB [AAB+ single] and n = 36 with multiple positive AABs [AAB+ multiple]), and patients with recent-onset type 1 diabetes (<1 year) (N = 52). Fasting subjects underwent 1.5T pancreatic MRI, and PV and relative PV (RPV) (PV-to-BMI ratio) were analyzed between groups and for correlations with HbA1c, C-peptide, glucose, and trypsinogen. RESULTS: All FDR groups had significantly lower RPV adjusted for BMI (RPVBMI) than control subjects (all P < 0.05). Patients with type 1 diabetes had lower RPVBMI than AAB- FDR (P < 0.0001) and AAB+ multiple (P ≤ 0.013) subjects. Transformed data indicated that trypsinogen levels were lowest in patients with type 1 diabetes. CONCLUSIONS: This study demonstrates, for the first time, all FDRs having significantly smaller RPVBMI compared with AAB- control subjects. Furthermore, RPVBMI was significantly lower in patients with recent-onset type 1 diabetes than in the AAB- FDR and AAB+ multiple groups. As such, RPVBMI may be a novel noninvasive biomarker for predicting progression through stages of type 1 diabetes risk. This study highlights the potential paracrine relationships between the exocrine and endocrine pancreas in progression to type 1 diabetes in subjects at risk.
引用
- Campbell-Thompson ML, Filipp SL, Grajo JR, et al. Relative Pancreas Volume Is Reduced in First-Degree Relatives of Patients With Type 1 Diabetes. Diabetes Care. 2018. PMID: 30552130. doi:10.2337/dc18-1512
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。